SRC and colonic neoplasm: The decrease of CHK expression results in Src activation without affecting the level of Src phosphorylation at Y530, and enhanced the tumorigenicity including anchorage-independent cell growth and cell invasion of colon cancer cells (Zhu et al., 2008; Figure 2A).